Containment of COVID-19 in Ethiopia and implications for tuberculosis care and research.
Betacoronavirus
/ isolation & purification
COVID-19
COVID-19 Testing
Clinical Laboratory Techniques
Comorbidity
Coronavirus Infections
/ diagnosis
Delivery of Health Care
Epidemiological Monitoring
Ethiopia
/ epidemiology
Female
Humans
Male
Pandemics
/ prevention & control
Patient Care
Pneumonia, Viral
/ diagnosis
Quarantine
SARS-CoV-2
Travel
/ statistics & numerical data
Tuberculosis
/ diagnosis
COVID-19
Containment
Coronavirus
Ethiopia
Public health
Tuberculosis
Journal
Infectious diseases of poverty
ISSN: 2049-9957
Titre abrégé: Infect Dis Poverty
Pays: England
ID NLM: 101606645
Informations de publication
Date de publication:
16 Sep 2020
16 Sep 2020
Historique:
received:
18
05
2020
accepted:
08
09
2020
entrez:
17
9
2020
pubmed:
18
9
2020
medline:
25
9
2020
Statut:
epublish
Résumé
The coronavirus disease 2019 (COVID-19) has emerged as a global health and economic security threat with staggering cumulative incidence worldwide. Given the severity of projections, hospitals across the globe are creating additional critical care surge capacity and limiting patient routine access to care for other diseases like tuberculosis (TB). The outbreak fuels panic in sub-Saharan Africa where the healthcare system is fragile in withstanding the disease. Here, we looked over the COVID-19 containment measures in Ethiopia in context from reliable sources and put forth recommendations that leverage the health system response to COVID-19 and TB. Ethiopia shares a major proportion of the global burden of infectious diseases, while the patterns of COVID-19 are still at an earlier stage of the epidemiology curve. The Ethiopian government exerted tremendous efforts to curb the disease. It limited public gatherings, ordered school closures, directed high-risk civil servants to work from home, and closed borders. It suspended flights to 120 countries and restricted mass transports. It declared a five-month national state of emergency and granted a pardon for 20 402 prisoners. It officially postponed parliamentary and presidential elections. It launched the 'PM Abiy-Jack Ma initiative', which supports African countries with COVID-19 diagnostics and infection prevention and control commodities. It expanded its COVID-19 testing capacity to 38 countrywide laboratories. Many institutions are made available to provide clinical care and quarantine. However, the outbreak still has the potential for greater loss of life in Ethiopia if the community is unable to shape the regular behavioral and sociocultural norms that would facilitate the spread of the disease. The government needs to keep cautious that irregular migrants would fuel the disease. A robust testing capacity is needed to figure out the actual status of the disease. The pandemic has reduced TB care and research activities significantly and these need due attention. Ethiopia took several steps to detect, manage, and control COVID-19. More efforts are needed to increase testing capacity and bring about behavioral changes in the community. The country needs to put in place alternative options to mitigate interruptions of essential healthcare services and scientific researches of significant impact.
Sections du résumé
BACKGROUND
BACKGROUND
The coronavirus disease 2019 (COVID-19) has emerged as a global health and economic security threat with staggering cumulative incidence worldwide. Given the severity of projections, hospitals across the globe are creating additional critical care surge capacity and limiting patient routine access to care for other diseases like tuberculosis (TB). The outbreak fuels panic in sub-Saharan Africa where the healthcare system is fragile in withstanding the disease. Here, we looked over the COVID-19 containment measures in Ethiopia in context from reliable sources and put forth recommendations that leverage the health system response to COVID-19 and TB.
MAIN TEXT
METHODS
Ethiopia shares a major proportion of the global burden of infectious diseases, while the patterns of COVID-19 are still at an earlier stage of the epidemiology curve. The Ethiopian government exerted tremendous efforts to curb the disease. It limited public gatherings, ordered school closures, directed high-risk civil servants to work from home, and closed borders. It suspended flights to 120 countries and restricted mass transports. It declared a five-month national state of emergency and granted a pardon for 20 402 prisoners. It officially postponed parliamentary and presidential elections. It launched the 'PM Abiy-Jack Ma initiative', which supports African countries with COVID-19 diagnostics and infection prevention and control commodities. It expanded its COVID-19 testing capacity to 38 countrywide laboratories. Many institutions are made available to provide clinical care and quarantine. However, the outbreak still has the potential for greater loss of life in Ethiopia if the community is unable to shape the regular behavioral and sociocultural norms that would facilitate the spread of the disease. The government needs to keep cautious that irregular migrants would fuel the disease. A robust testing capacity is needed to figure out the actual status of the disease. The pandemic has reduced TB care and research activities significantly and these need due attention.
CONCLUSIONS
CONCLUSIONS
Ethiopia took several steps to detect, manage, and control COVID-19. More efforts are needed to increase testing capacity and bring about behavioral changes in the community. The country needs to put in place alternative options to mitigate interruptions of essential healthcare services and scientific researches of significant impact.
Identifiants
pubmed: 32938497
doi: 10.1186/s40249-020-00753-9
pii: 10.1186/s40249-020-00753-9
pmc: PMC7492795
doi:
Types de publication
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
131Subventions
Organisme : FIC NIH HHS
ID : D43 TW009127
Pays : United States
Organisme : Medical Research Council
ID : MR/M025470/1
Pays : United Kingdom
Organisme : FIC NIH HHS
ID : D43TW009127
Pays : United States
Références
PLoS One. 2019 Nov 13;14(11):e0224277
pubmed: 31721767
Infect Dis Poverty. 2020 Jul 16;9(1):96
pubmed: 32678037
J Clin Tuberc Other Mycobact Dis. 2020 Mar 05;19:100158
pubmed: 32258437
Lancet Respir Med. 2020 Jun;8(6):536-538
pubmed: 32220280
BMJ Open. 2020 Jun 16;10(6):e035272
pubmed: 32554739
Nat Med. 2020 Jun;26(6):811-812
pubmed: 32398877
Int J Tuberc Lung Dis. 2020 Jun 1;24(6):643-645
pubmed: 32553005
Int J Tuberc Lung Dis. 2020 May 1;24(5):550-552
pubmed: 32398216
Trop Med Health. 2020 May 13;48:32
pubmed: 32425653
Ann Clin Microbiol Antimicrob. 2020 May 23;19(1):21
pubmed: 32446305
Int J Tuberc Lung Dis. 2020 May 1;24(5):542-544
pubmed: 32398211
Trials. 2020 May 5;21(1):383
pubmed: 32370774
S Afr Med J. 2020 Mar 27;110(5):341-342
pubmed: 32657710